|
|
Br J Cancer. 1993 July; 68(1): 151–155. | PMCID: PMC1968309 |
Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma. H. R. Haak, C. J. Cornelisse, J. Hermans, L. Cobben, and G. J. Fleuren Department of Endocrinology, University Hospital Leiden, The Netherlands. Abstract Prognostic factors are needed for the management of patients with adrenocortical tumours. For this reason, the nuclear DNA content of patients with adrenocortical tumours was analysed by flow cytometry. The relationships between nuclear DNA content, histological indices, and clinical parameters were studied. DNA ploidy could be evaluated in 54 carcinoma and 31 adenoma patients. Twenty-one (68%) of the adenomas, and 6 (11%) of the carcinomas, were DNA diploid. Hypo/Hyperdiploidy was found in 5 (16%) of the adenomas, and 15 (28%) of the carcinomas. The remaining patients had a DNA index above 1.40. A shorter survival was found in patients with diploid carcinomas (P < 0.05). A longer disease-free survival was seen in patients with hypo/hyperdiploid carcinomas (P < 0.05). Nuclear DNA content was not related to the histological index, nor to clinical parameters. We conclude that nuclear DNA content is related to (disease-free) survival of patients with adrenocortical carcinomas. An adenoma-carcinoma sequence may be present in the adrenal cortex. In adrenocortical tumours ploidy evolution appears to be different than that observed in other solid tumours. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (957K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Abramowsky CR, Taylor SR, Anton AH, Berk AI, Roederer M, Murphy RF. Flow cytometry DNA ploidy analysis and catecholamine secretion profiles in neuroblastoma. Cancer. 1989 May 1;63(9):1752–1756. [PubMed]
- Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer. 1990 Jan 15;45(1):34–39. [PubMed]
- Cornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry. 1987 Mar;8(2):225–234. [PubMed]
- Gansler T, Chatten J, Varello M, Bunin GR, Atkinson B. Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome. Cancer. 1986 Dec 1;58(11):2453–2458. [PubMed]
- Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. [PubMed]
- Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry. 1989 May;10(3):229–241. [PubMed]
- Hosaka Y, Rainwater LM, Grant CS, Young WF, Jr, Farrow GM, van Heerden JA, Lieber MM. Adrenocortical carcinoma: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. Surgery. 1987 Dec;102(6):1027–1034. [PubMed]
- Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol. 1979 Sep;72(3):390–399. [PubMed]
- Joensuu H, Klemi P, Eerola E, Tuominen J. Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer. 1986 Dec 1;58(11):2462–2467. [PubMed]
- Joensuu H, Klemi PJ. DNA aneuploidy in adenomas of endocrine organs. Am J Pathol. 1988 Jul;132(1):145–151. [PubMed]
- Kaneko Y, Kanda N, Maseki N, Sakurai M, Tsuchida Y, Takeda T, Okabe I, Sakurai M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 1987 Jan 1;47(1):311–318. [PubMed]
- Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984 Jul 26;311(4):231–235. [PubMed]
- Moolenaar AJ, Niewint JW, Oei IT. Estimation of o,p'-DDD in plasma by gas-liquid chromatography. Clin Chim Acta. 1977 Apr 15;76(2):213–218. [PubMed]
- Oppedal BR, Storm-Mathisen I, Lie SO, Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer. 1988 Aug 15;62(4):772–780. [PubMed]
- Padberg BC, Lauritzen I, Achilles E, Holl K, Bressel M, Klöppel G, Dralle H, Schröder S. DNA cytophotometry in adrenocortical tumours: a clinicomorphological study of 66 cases. Virchows Arch A Pathol Anat Histopathol. 1991;419(3):167–170. [PubMed]
- Rodenburg CJ, Cornelisse CJ, Heintz PA, Hermans J, Fleuren GJ. Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer. 1987 Jan 15;59(2):317–323. [PubMed]
- Samaan NA, Hickey RC. Adrenal cortical carcinoma. Semin Oncol. 1987 Sep;14(3):292–296. [PubMed]
- Schelfhout LJ, Cornelisse CJ, Goslings BM, Hamming JF, Kuipers-Dijkshoorn NJ, van de Velde CJ, Fleuren GJ. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms. Int J Cancer. 1990 Jan 15;45(1):16–20. [PubMed]
- van Slooten H, Moolenaar AJ, van Seters AP, Smeenk D. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring. Eur J Cancer Clin Oncol. 1984 Jan;20(1):47–53. [PubMed]
- van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer. 1985 Feb 15;55(4):766–773. [PubMed]
- Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):323–327. [PubMed]
- Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984 Mar;8(3):163–169. [PubMed]
|
This article has been